A detailed history of Blackstone Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Blackstone Inc holds 491,043 shares of NKTX stock, worth $1.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
491,043
Previous 236,190 107.9%
Holding current value
$1.15 Million
Previous $1.4 Million 59.07%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $1.15 Million - $2.04 Million
254,853 Added 107.9%
491,043 $2.22 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $1.24 Million - $2.56 Million
236,190 New
236,190 $1.4 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.